PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-κB

被引:0
作者
H. Bark
Cheol-Hee Choi
机构
[1] Chosun University Medical School,Department of Pharmacology, Research Center for Resistant Cells
来源
Cancer Chemotherapy and Pharmacology | 2010年 / 65卷
关键词
Multidrug resistance; PSC833; P-glycoprotein; JNK; C-jun; AP-1; NF-kB;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1131 / 1136
页数:5
相关论文
共 148 条
[1]  
Barkett M(1999)Control of apoptosis by Rel/NF-kappaB transcription factors Oncogene 18 6910-6924
[2]  
Gilmore TD(2003)NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells Oncogene 22 90-97
[3]  
Bentires-Alj M(1991)In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833 Cancer Res 51 4226-4233
[4]  
Barbu V(1986)Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell 47 381-389
[5]  
Fillet M(1992)Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 258 1650-1654
[6]  
Chariot A(2002)Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor Cell Signal 14 585-593
[7]  
Relic B(1989)The biochemistry of P-glycoprotein-mediated multidrug resistance Annu Rev Biochem 58 137-171
[8]  
Jacobs N(2006)Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95): a trial of the Eastern Cooperative Oncology Group Cancer 106 830-838
[9]  
Gielen J(2002)Missing pieces in the NF-kappaB puzzle Cell 109 S81-S96
[10]  
Merville MP(1993)Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists J Biol Chem 268 2946-2952